1. Hogg RS, Yip B, Kully C, et al.: Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens. CMAJ 1999, 160:659–665.
2. Hammer SM, Squires KE, Hughes MD, et al.: A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N Engl J Med 1997, 337:725–733.
3. Rabkin JG, Chesney M: Treatment adherence to HIV medications: The Achilles heel of the new therapeutics. In New HIV therapies: Psychological and public health implications. Edited by Ostrow D, Kalichman S. New York: Plenum Press; 1999.
4. Friedland GH, Williams A: Attaining higher goals in HIV treatment: the central importance of adherence. AIDS 1999, 13(Suppl 1):S61–72.
5. Hecht FM: Measuring HIV treatment adherence in clinical practice. AIDS Clin Care 1998, 10:57–59.